Ofloxacin Pricing Report ​2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Ofloxacin Pricing Report ​2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Report Format: PDF+Excel | Report ID: SR112024A23145
Buy Now

Ofloxacin Prices December 2023

Category Region Price
Ofloxacin Pharma API USA 41645 USD/MT (Jun, 23)
Ofloxacin Pharma API China 4805 USD/MT (API) (Jun, 23)
Ofloxacin Pharma API Germany 46645 USD/MT (Jun, 23)

The US dollar loss against the other currencies in the first place trimmed down the trade, which made Ofloxacin more expensive to US buyers, this further led to downward pressure on prices. Conversely, June recorded an increase in prices. Local ofloxacin suppliers can supply the domestic market fully. Moreover, there was a 0.1% rise in the US consumer price index (CPI) in June 2023. This led to prices for Ofloxacin at a rate of USD 41645/MT CFR Los Angeles.

The latest appreciation of the Chinese Yuan vis-à-vis the US dollar resulted in higher costs of various commodities including Ofloxacin worldwide. To remain competitive in the market, traders and manufacturers reduced their selling prices. Consequently, the pharmaceutical API market saw improvement at the finality of Q2-2023. While the CPI recorded a 0.2% increase in June 2023 in China, manufacturing remained sluggish. Consequently, the price of Ofloxacin API was set at USD 4805/MT FOB Shanghai.

In Germany, prices were supported by weakness in the German Purchasing Manager Index (PMI) which fell to 52.2 from 54.8 in May. During Q2, the Ofloxacin prices adjusted with the stabilization at USD 46645/MT CFR Hamburg which displayed a progressive incremental pattern. The participants in the market ensured that adequate stocks were available to meet total demand, which, in part, was the reason why the prices remained stable.

Ofloxacin Price Trend, Market Analysis, and News

IMARC’s newly published report, titled Ofloxacin Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data, offers an in-depth analysis of ofloxacin pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot prices at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of price trends across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing ofloxacin price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Ofloxacin Price Trend

Ofloxacin Market Analysis

The global ofloxacin market is expected to project a CAGR of 4.20% during 2023-2032.

  • The development of bacterial infections is the major factor that affects the ofloxacin market. As per the data provided by the Centers for Disease Control and Prevention (CDC), antibiotic-resistant bacteria cause nearly 2.8 million infections and approximately 35,000 deaths in the United States every year. As a broad-spectrum antibiotic, Ofloxacin plays a pivotal role in the treatment of various bacterial infections that affect the respiratory, urinary, and skin tract. Moreover, the rise of these diseases will be the main driver of Ofloxacin consumption, thereby propelling market growth. This is indicative of the increasing dependence on effective antibiotic therapy in dealing with the public health challenges associated with bacterial infection.
  • The fast-growing antibiotic use in developing economies majorly influences the ofloxacin market. In line with the latest statistics, the spread of antibiotic use especially in low- and middle-income countries has registered an outburst. This increase is due to better healthcare access, economic conditions, and increased attention to bacterial infections. Ofloxacin (well-known for its high-cost effectiveness and broad-spectrum antibacterial activity), is especially favored in these regions. The rise of infectious diseases and investment, which can cater to better healthcare, creates the momentum for drugs like ofloxacin. This trend is supported by a significant uptake of antibiotics in those states, which suggests thus an upward trajectory of the ofloxacin market in emerging economies.
  • The rapid growth of the ofloxacin market is driven by the development of novel transportation systems for drugs. Nanotechnology factors and nanoparticles are utilized to increase the effectiveness and safety of ofloxacin. As these superior delivery techniques can improve the bioavailability of the drug, it, therefore, allows for more effective treatment with potentially lower doses, hence reducing the risk of side effects. For instance, the authors of the journal article in the Journal of Pharmaceutical Sciences pointed out that the NPs loaded with ofloxacin had better bioavailability and less toxicity in comparison with traditional formulations. The continuous evolution of drug delivery technology besides the therapeutic value of ofloxacin as a treatment tool for infections catalyzes the market expansion​.

Ofloxacin News

The report covers the latest developments, updates, and trends impacting the global ofloxacin market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in ofloxacin production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that shape the industry landscape.

Latest developments in the ofloxacin industry:

  • In March 2021, Vivimed Labs Ltd., a major player of global specialty chemicals and medicines that came from India, got permission issued for a combination consisting of Ornidazole and Ofloxacin tablets. Besides, this mix is prepared for treating a broad range of bacteria and protozoan infections which allow a wider use of ofloxacin in medicine. The approval reflects a major progression as it eminently combines the broad-spectrum antibacterial nature of Ofloxacin with the antiprotozoal nature of Ornidazole, potentially raising the remedial efficacy against dual-infection scenarios. This highlights the fact that unremitting innovations in pharmaceutical formulations and the availability of combined therapy to address complex infectious diseases are concomitant efforts.

Product Description

Ofloxacin is a quinolone antibiotic from the class of fluoroquinolones used for the treatment of several bacterial infections. It functions by suppressing bacterial DNA gyrase, an enzyme that is irreducible for DNA replication, eventually leading to the inadequate growth of bacteria. Ofloxacin can combat a broad family of bacteria which includes both Gram-positive and Gram-negative organisms.

Doctors and other health care providers use Ofloxacin to treat infections of the urinary tract, respiratory tract, skin, sexually transmitted infections, and certain eye infections, such as conjunctivitis. It can be found in various forms, such as tablets, eye drops, and intravenous injections.

Generally, Ofloxacin is well tolerated but it may produce some side effects such as nausea, diarrhea, headache, and dizziness. Rare and life-threatening adverse effects are tendon rupture, nerve damage, and allergic reactions. Owing to the adverse effects risk, such as tendon damage and the central nervous system effects, it is usually used in cases where other antibiotics remain ineffective or inappropriate.

Regional Coverage

The report provides a detailed analysis of the ofloxacin market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the price trends. 

Global Ofloxacin Price

The report offers a holistic view of the global ofloxacin pricing trends, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level.

Europe Ofloxacin Price

In Europe, the second quarter price chart of ofloxacin observed a similar trend as that of the United States, which began with a gradual rise until April and was followed by a sharp fall in May and a slow recovery in June. April’s price surge was maintained by stable demand that was further strengthened by continued production activities amidst excellent merchant stock levels. On the other hand, May had a drastic fall which might result from the slump of demand dynamics as well as inventory adjustments, or government regulations. With that said, June witnessed a stabilization in prices signaling the restoration of the equilibrium in the market, which is possibly caused by renewed demand or supply changes.

This analysis can be extended to include detailed ofloxacin price information for a comprehensive list of countries.

Region Countries Covered
Europe Germany, France, United Kingdom, Italy,  Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.

North America Ofloxacin Price

In North America, in the second quarter of 2023, ofloxacin prices experienced an upward trend was marked by a significant jump in investor probity from the previous month, attracting investors from the local pharmaceutical and healthcare industry. But in May, they dropped by 2 percent from the previous month. This decline was the result of low demand, oversupply, and depreciation. The confluence of all these factors led to a regional drop in Ofloxacin prices across North America for the month. While the recession may increase volatility in the market, stakeholders in the pharmaceutical industry will continuously have to be watchful for these changing dynamics.

Specific data on ofloxacin prices within the United States and Canada can also be provided.

Region Countries Covered
North America United States and Canada

Middle East and Africa Ofloxacin Price

The report explores the ofloxacin pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on ofloxacin prices for countries can also be provided.

Region Countries Covered
Middle East & Africa Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.

Asia Pacific Ofloxacin Price

In Asia-Pacific in the 2nd quarter of 2023, the price of ofloxacin, an active pharmaceutical ingredient (API), displayed an indecisive pattern that echoed the sentiment of April's stock market. In the beginning, the growth was moderate and was corresponding with the feelings of the previous month. The consumption rates were the same in April as they were both at home and abroad. Such stability in demand provided the basis for the durable pricing trajectory. Nevertheless, the volatile market sentiment hints at certain uncertainties that may influence the price of ofloxacin as well. Therefore, such alterations are of key interest to the pharmaceutical industry stakeholders for the development of adaptive strategies in response to changing market conditions.

The ofloxacin pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This analysis can be further extended to include detailed ofloxacin prices for a comprehensive list of countries within the region.

Region Countries Covered
Asia Pacific China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.

Latin America Ofloxacin Price

The analysis of ofloxacin prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Region Countries Covered
Latin America Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.

Report Coverage

Key Attributes Details
Product Name Ofloxacin
Report Features Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Price Analysis, and Segment-Wise Assessment.
Currency/Units US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered The current coverage includes analysis at the global and regional levels only. 
Based on your requirements, we can also customize the report and provide specific information for the following countries: 
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* 
North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*

Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*

*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers
  • Company Overview
  • Business Description
  • Product Portfolio
  • Recent Trends and Developments
Customization Scope The report can be customized as per the requirements of the customer
Report Price and Purchase Option

Plan A: Monthly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Month
    • Forecast for Next Month
  • Total Deliverables Per Year: 12 (One Per Month)
  • Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year

Plan B: Quarterly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Quarter
    • Forecast for Next Quarter
  • Total Deliverables Per Year: 4 (One Per Quarter)
  • Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year

Plan C: Biannually Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Half
    • Forecast for the Next Half
  • Total Deliverables Per Year: 2 (One Per 6 Months)
  • Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year  
Post-Sale Analyst Support  360-degree analyst support after report delivery
Delivery Format PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) 

Key Benefits for Stakeholders:

  • IMARC’s report presents a detailed analysis of ofloxacin pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
  • The study examines factors affecting ofloxacin price volatility, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
  • The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
  • IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the ofloxacin industry.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Ofloxacin Pricing Report ​2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Purchase options
For 2 Deliverables, Billed Annually

For 4 Deliverables, Billed Annually

For 12 Deliverables, Billed Annually

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More